Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Quantitative Phosphoproteomics Reveals Extensive Protein Phosphorylation Dysregulation in the Cerebral Cortex of Huntington’s Disease Mice Prior to Onset of Symptoms
Isaline Mees, Harvey Tran, Anne M. Roberts, et al.
Molecular Neurobiology (2022) Vol. 59, Iss. 4, pp. 2456-2471
Closed Access | Times Cited: 19

Showing 19 citing articles:

Genetic forms of tauopathies: inherited causes and implications of Alzheimer’s disease-like TAU pathology in primary and secondary tauopathies
Felix Langerscheidt, Tamara Wied, Mohamed Aghyad Al Kabbani, et al.
Journal of Neurology (2024) Vol. 271, Iss. 6, pp. 2992-3018
Open Access | Times Cited: 13
Abnormal protein post-translational modifications induces aggregation and abnormal deposition of protein, mediating neurodegenerative diseases
Wei Li, Honglian Li, Jian‐Zhi Wang, et al.
Cell & Bioscience (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 9
Untangling the Role of Tau in Huntington’s Disease Pathology
Shireen Salem, Francesca Cicchetti
Journal of Huntington s Disease (2023) Vol. 12, Iss. 1, pp. 15-29
Open Access | Times Cited: 13
Brain-Derived Neurotrophic Factor Dysregulation as an Essential Pathological Feature in Huntington’s Disease: Mechanisms and Potential Therapeutics
Andrew Speidell, Noman Bin Abid, Hiroko Yano
Biomedicines (2023) Vol. 11, Iss. 8, pp. 2275-2275
Open Access | Times Cited: 13
Ubiquitin specific peptidase 11 knockdown slows Huntington’s disease progression via regulating mitochondrial dysfunction and neuronal damage depending on PTEN-mediated AKT pathway
Bai Gao, Yuchen Jing, Xi Li, et al.
Molecular Medicine (2025) Vol. 31, Iss. 1
Open Access
Implications of Tau Dysregulation in Huntington’s Disease and Potential for New Therapeutics
Isaline Mees, Rebecca M. Nisbet, Anthony J. Hannan, et al.
Journal of Huntington s Disease (2023) Vol. 12, Iss. 1, pp. 1-13
Open Access | Times Cited: 12
Protein Aggregation and its Affecting Mechanisms in Neurodegenerative Diseases.
Junyun Wu, Jianan Wu, Tao Chen, et al.
Neurochemistry International (2024) Vol. 180, pp. 105880-105880
Closed Access | Times Cited: 3
Phosphoregulation of the septin cytoskeleton in neuronal development and disease
Bailey Werner, Smita Yadav
Cytoskeleton (2022) Vol. 80, Iss. 7-8, pp. 275-289
Closed Access | Times Cited: 15
Phosphoproteomic dysregulation in Huntington’s disease mice is rescued by environmental enrichment
Isaline Mees, Shanshan Li, Harvey Tran, et al.
Brain Communications (2022) Vol. 4, Iss. 6
Open Access | Times Cited: 13
Evidence of mutant huntingtin and tau-related pathology within neuronal grafts in Huntington’s disease cases
Shireen Salem, Mitchell D. Kilgore, Mehwish Anwer, et al.
Neurobiology of Disease (2024) Vol. 198, pp. 106542-106542
Open Access | Times Cited: 2
Phosphoproteomic analysis of neoadjuvant breast cancer suggests that increased sensitivity to paclitaxel is driven by CDK4 and filamin A
Silvana Mourón, María José Sánchez Bueno, Aña Lluch, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 11
Proteostatic modulation in brain aging without associated Alzheimer’s disease-and age-related neuropathological changes
Pol Andrés‐Benito, Ignacio Íñigo-Marco, Marta Brullas, et al.
Aging (2023) Vol. 15, Iss. 9, pp. 3295-3330
Open Access | Times Cited: 5
The Potential Role of Artemisinins Against Neurodegenerative Diseases
Lei Xia, Yiqiong Qiu, Junjie Li, et al.
The American Journal of Chinese Medicine (2024), pp. 1-20
Closed Access | Times Cited: 1
Superhydrophilic nanocomposite adsorbents modified via nitrogen-rich phosphonate-functionalized ionic liquid linkers: enhanced phosphopeptide enrichment and phosphoproteome analysis of tau phosphorylation in the hippocampal lysate of Alzheimer's transgenic mice
Chenglong Xia, Qiyao Wang, Weida Liang, et al.
Journal of Materials Chemistry B (2022) Vol. 10, Iss. 39, pp. 7967-7978
Closed Access | Times Cited: 4
Ubiquitin Specific Peptidase 11 Knockdown Slows Huntington's Disease Progression via Regulating Mitochondrial Dysfunction and Neuronal Apoptosis Depending on PTEN- mediated AKT Pathway
Bai Gao, Yuchen Jing, Xi Li, et al.
Research Square (Research Square) (2024)
Closed Access
Unknown roles of tau pathology in neurological disorders. Challenges and new perspectives
Margrethe A. Olesen, Francisca Villavicencio-Tejo, Víctor Cuevas-Espinoza, et al.
Ageing Research Reviews (2024), pp. 102594-102594
Closed Access
Phosphoproteomics implicates glutamatergic and dopaminergic signalling in the antidepressant-like properties of the iron chelator deferiprone
Volkan Uzungil, Sandra Luza, Carlos Opazo, et al.
Neuropharmacology (2024) Vol. 246, pp. 109837-109837
Open Access
Phosphoproteomics implicates glutamatergic and dopaminergic signalling in the antidepressant-like properties of the iron chelator deferiprone
Volkan Uzungil, Sandra Luza, Carlos Opazo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Exploring the Benefits of Trimethylation Enhancement using Diazomthane (TrEnDi) in Mass Spectropmetry-Based Phosphoproteomics
Samiksha Vij
(2023)
Open Access
Page 1

Scroll to top